All the three COVID-19 vaccine candidates Vietnam is developing are currently in the stage of clinical trials, and if they are qualified as assessed by the ethics and advisory councils, the Ministry of Health (MoH) will grant licenses, an official has said.
The National Ethics Committee in Biomedical Research under the Ministry of Health has requested additional reports on the protective efficacy of the homegrown candidate COVID-19 vaccine Nano Covax, requiring that they should be submitted before 3pm on December 22 for review.
The National Ethics Committee in Biomedical Research under the Ministry of Health on September 19 issued a press statement on its conclusions of a meeting one day earlier during which it looked into the mid-term phase 3 trial’s results of homegrown COVID-19 vaccine Nano Covax.
Deputy Prime Minister Vu Duc Dam has asked for completion of the dossier of the homegrown Nano Covax vaccine to submit for urgent licencing, and assistance for relevant firms in testing the anti-virus drug Molnupiravir in a notice released by the Government Office.
Nanogen Pharmaceutical Biotechnology JSC was asked to provide more information regarding safety, immunogenicity, and protection effects before a registration certificate of circulation for its Nano Covax can be granted, Deputy Minister of Health Tran Van Thuan has said.
Nanogen Pharmaceutical Biotechnology JSC has been asked to provide more data for consideration before a registration certificate of conditional circulation for its Nano Covax can be granted.
The National Committee for Ethics in Biomedical Research under the Ministry of Health (MoH) has agreed that the mid-term results from Nano Covax's phase 3 clinical trials will be submitted to the Advisory Council for the Registration of Circulation of Drugs and Medicinal Ingredients for considering the issuance of a registration certificate for the conditional circulation of the vaccine.
The National Ethics Committee in Biomedical Research under the Ministry of Health on August 7 held an urgent online meeting to review the results of the first phase of clinical trials of Vietnam’s domestically developed COVID-19 vaccine, Nano Covax, and to pass the mid-term assessment of its second phase.
The Ministry of Health (MoH), in collaboration with the World Health Organisation (WHO), organised a webinar on August 4 to consult experts on the evaluation of clinical research data and emergency approval of COVID-19 vaccines.
The Ministry of Health in collaboration with the World Health Organisation organized a webinar on August 4 to consult experts on the evaluation of clinical research data and approval of vaccines against COVID-19 in emergency situations.
Research centres on July 27 began the injection of the second shots of COVID-19 Nano Covax vaccine for 12,000 volunteers as part of the third-phase human trials of the home-grown vaccine, according to the Military Medical University under the Ministry of National Defence.
More than 1,000 volunteers received their second shots of homegrown Nano Covax vaccine in its third phase of human trials, as announced by the Defence Ministry’s Military Medical University on July 19.
More than 900 out of 12,000 volunteers participating in the second stage of the third phase of the homegrown COVID-19 vaccine Nano Covax’s clinical trial got their first shots on July 2.
The Ministry of Health and the National Council of Ethics in Biomedical Research on June 25 agreed with the Pasteur Institute in Ho Chi Minh City and the Military Medical University to speed up the third-phase clinical trial of the homegrown COVID-19 vaccine Nano Covax on all the 13,000 volunteers.
The administration of the first 1,000 shots in the third-phase trials of Nano Covax, a home-grown COVID-19 vaccine candidate, has completed, the Hanoi-based Vietnam Military Medical University said.
Vietnam’s national count of COVID-19 cases has crossed the milestone of 10,000 more than a month after the resurgence of the virus began in late April, wreaking havoc on multiple major industrial parks where thousands of factory workers have become infected.
The third-phase clinical trial of Vietnam’s first home-grown COVID-19 vaccine, Nano Covax, began on June 10. Being developed by the Nanogen Pharmaceutical Biotechnology JSC based on recombinant DNA/protein technology, the vaccine has undergone two trial phases and proved to be effective against the UK and South African variants.
The first 240 volunteers in the third phase of the human trials of the home-grown Nano Covax COVID-19 vaccine received shots at the Vietnam Military Medical University in Hanoi on June 11.
Health
